investment

As women’s health investment continues to bloom, autoimmune and inflammatory diseases (AIIDs) are an under-recognized opportunity. Despite an astonishing 75-80% of autoimmune patients being female, AIIDs are rarely included under the wide umbrella of women’s health. Even big healthcare systems have largely ignored AIIDs, especially in women. AIIDs remain a